Welcome to the 6th Gene Therapy Analytical Development Summit Europe
Join the community advancing analytics & QC from Pre-IND/IMPD to BLA
The 6th Gene Therapy Analytical Development Summit Europe is the premier platform for advancing gene therapy analytics, empowering you to overcome challenges and fast-track therapies through IND/IMPD filings, clinical trials, and regulatory approvals.
With the gene therapy field progressing toward late-stage development, and hurdles like Rocket Pharma’s KRESLADI rejection spotlighting critical gaps in CMC data, this summit provides timely, industry-focused insights tailored for the European market.
Join 24+ expert speakers to tackle characterisation, stability studies, contamination risks, and comparability across vectors and diseases.
Network with biotech, pharma, the MHRA and British Pharmacopoeia, share innovative solutions, and shape the future of gene therapy. Don’t miss the only European event dedicated to driving analytical precision, QC strategy and delivering safe, effective therapies to patients worldwide.
World-Class Speaker Faculty Includes:
Alicja Fiedorowicz
ATMP Working Group Scientific Lead
Association of the British Pharmaceutical Industry
Femke De Keijzer Van De Water
Associate Director - Scientific, Cell Gene Therapy Analytics & Advanced Therapy Analytics
Johnson & Johnson
Previously Attending Companies Include:
Our Partners:
